Skip to Main Content

Author Details

Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
1999
88
36
PMIDPaper TitleJournal TitlePublished Year
34789422Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.Eur Urol Oncol2023
37747813Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.Clin Cancer Res2023
37454202Actionability classification of variants of unknown significance correlates with functional effect.NPJ Precis Oncol2023
36930815Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.Cancer2023
34789422Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.Eur Urol Oncol2023
37747813Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.Clin Cancer Res2023
37454202Actionability classification of variants of unknown significance correlates with functional effect.NPJ Precis Oncol2023
36930815Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.Cancer2023
34990212Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in Cancer.JCO Clin Cancer Inform2022
36239938Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.JAMA Netw Open2022
34990212Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in Cancer.JCO Clin Cancer Inform2022
35108036Clinical and Molecular Characterization of <i>POLE</i> Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.JCO Precis Oncol2022
35138907A functional genomic approach to actionable gene fusions for precision oncology.Sci Adv2022
36239938Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.JAMA Netw Open2022
35138907A functional genomic approach to actionable gene fusions for precision oncology.Sci Adv2022
35108036Clinical and Molecular Characterization of <i>POLE</i> Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.JCO Precis Oncol2022
34476331Retrospective Case Series Analysis of <i>RAF</i> Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies.JCO Precis Oncol2021
34853384Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition.NPJ Precis Oncol2021
34638434<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.Cancers (Basel)2021
34476331Retrospective Case Series Analysis of <i>RAF</i> Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies.JCO Precis Oncol2021
34853384Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition.NPJ Precis Oncol2021
34638434<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.Cancers (Basel)2021
32134465Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy Specimens.JAMA Netw Open2020
32079540Comprehensive assessment of computational algorithms in predicting cancer driver mutations.Genome Biol2020
31852833Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer.Clin Cancer Res2020
32134465Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy Specimens.JAMA Netw Open2020
32580150HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs.Endocr Relat Cancer2020
32733093Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.Br J Cancer2020
32620919Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.Mod Pathol2020
32079540Comprehensive assessment of computational algorithms in predicting cancer driver mutations.Genome Biol2020
31852833Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer.Clin Cancer Res2020
32580150HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs.Endocr Relat Cancer2020
32733093Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.Br J Cancer2020
32620919Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.Mod Pathol2020
30446581Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.Oncologist2019
31825821A Deep Learning Framework for Predicting Response to Therapy in Cancer.Cell Rep2019
32923868Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA.JCO Precis Oncol2019
32923865Targeting <i>ERBB2</i> (<i>HER2</i>) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications.JCO Precis Oncol2019
32914008Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced Cancers.JCO Precis Oncol2019
35100667Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer.JCO Precis Oncol2019
30446581Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.Oncologist2019
30420449Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations.Clin Cancer Res2019
30376375Confocal Fluorescence Microscopy Platform Suitable for Rapid Evaluation of Small Fragments of Tissue in Surgical Pathology Practice.Arch Pathol Lab Med2019
30926639Prospective Clinical Sequencing of Adult Glioma.Mol Cancer Ther2019
31517177Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.JCO Precis Oncol2019
31265323OCTANE: Oncology Clinical Trial Annotation Engine.JCO Clin Cancer Inform2019
30995147The Status and Impact of Clinical Tumor Genome Sequencing.Annu Rev Genomics Hum Genet2019
31497255Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.Oncotarget2019
35100667Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer.JCO Precis Oncol2019
31825821A Deep Learning Framework for Predicting Response to Therapy in Cancer.Cell Rep2019
  • 1 - 50 of 176

Recommended Authors

Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 22
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 9
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 54
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 6
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 12
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 19
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Career Start Year 2006
Number of shared co-authors 2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 9
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 9
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 5
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 33
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 4
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 42
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 5
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 4
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 49
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 0
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 3
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 3
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 31
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 19
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 18
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 2
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 26
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 15
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 51
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 16
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 22
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 26

Collaborators

Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 51
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 40
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 26
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 18
Mark J Routbort
University of Texas MD Anderson Cancer Center
Co-authored papers 16
Elmer V Bernstam
The University of Texas Health Science Center at Houston
Co-authored papers 7
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Beom-Jun Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 6
Joan S Brugge
Co-authored papers 5
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Yiling Lu
Co-authored papers 4
Han Liang
MD Anderson Cancer Center
Co-authored papers 4
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 3
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 3
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers 3
Margi Sheth
Co-authored papers 3
Heidi J Sofia
National Human Genome Research Institute
Co-authored papers 3
Michael Mayo
Co-authored papers 3
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
Adrian Ally
Co-authored papers 3
Louise C Strong
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Jay Bowen
Nationwide Children's Hospital
Co-authored papers 3
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 3
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 3
Release 1.2